Literature DB >> 17923634

Asian origin for the worldwide-spread mutational event in Machado-Joseph disease.

Sandra Martins1, Francesc Calafell, Claudia Gaspar, Virginia C N Wong, Isabel Silveira, Garth A Nicholson, Ewout R Brunt, Lisbeth Tranebjaerg, Giovanni Stevanin, Mingli Hsieh, Bing-Wen Soong, Leal Loureiro, Alexandra Dürr, Shoji Tsuji, Mitsunori Watanabe, Laura B Jardim, Paola Giunti, Olaf Riess, Laura P W Ranum, Alexis Brice, Guy A Rouleau, Paula Coutinho, António Amorim, Jorge Sequeiros.   

Abstract

BACKGROUND: Machado-Joseph disease is the most frequent dominant ataxia worldwide. Despite its frequency and presence in many populations, only 2 founder mutations have been suggested to explain its current geographic distribution.
OBJECTIVES: To trace back in history the main mutational events in Machado-Joseph disease, we aimed to assess ancestral haplotypes and population backgrounds, to date the mutations, and to trace the routes and time of introduction of the founder haplotypes in different populations. DESIGN, SETTING, AND PARTICIPANTS: We studied 264 families with Machado-Joseph disease from 20 different populations. Six intragenic single-nucleotide polymorphisms were used to determine ancestral mutational events; 4 flanking short tandem repeats were used to construct extended haplotypes and measure accumulation of genetic diversity over time within each lineage.
RESULTS: The worldwide-spread lineage, TTACAC, had its highest diversity in the Japanese population, where we identified the ancestral short tandem repeat-based haplotype. Accumulated variability suggested a postneolithic mutation, about 5774 +/- 1116 years old, with more recent introductions in North America, Germany, France, Portugal, and Brazil. As to the second mutational event, in the GTGGCA lineage, only 7 families (of 71 families) did not have Portuguese ancestry, although gene diversity was again smaller in Portuguese families (0.44) than in non-Portuguese families (0.93).
CONCLUSIONS: The worldwide-spread mutation may have first occurred in Asia and later been diffused throughout Europe, with a founder effect accounting for its high prevalence in Portugal; the other Machado-Joseph disease lineage is more recent, about 1416 +/- 434 years old, and its dispersion may be explained mainly by recent Portuguese emigration.

Entities:  

Mesh:

Year:  2007        PMID: 17923634     DOI: 10.1001/archneur.64.10.1502

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  18 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  Hereditary Ataxias in Cuba: A Nationwide Epidemiological and Clinical Study in 1001 Patients.

Authors:  Luis Velázquez-Pérez; Jacqueline Medrano-Montero; Roberto Rodríguez-Labrada; Nalia Canales-Ochoa; Jandy Campins Alí; Frank J Carrillo Rodes; Tania Rodríguez Graña; María O Hernández Oliver; Raul Aguilera Rodríguez; Yennis Domínguez Barrios; Reydenis Torres Vega; Lissi Flores Angulo; Noharis Y Cordero Navarro; Aldo A Sigler Villanueva; Osiel Gámez Rodríguez; Ilya Sagaró Zambrano; Nayime Y Navas Napóles; Javier García Zacarías; Orlando R Serrano Barrera; María B Ramírez Bautista; Annelié Estupiñán Rodríguez; Leonardo A Guerra Rondón; Yaimeé Vázquez-Mojena; Yanetza González-Zaldivar; Luis E Almaguer Mederos; Alejandro Leyva-Mérida
Journal:  Cerebellum       Date:  2020-04       Impact factor: 3.847

Review 3.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

4.  A pathogenic variant in CHEK2 shows a founder effect in Portuguese Roma patients with thyroid cancer.

Authors:  Carolina Pires; Inês Jorge Marques; Daniela Dias; Ana Saramago; Valeriano Leite; Branca Maria Cavaco
Journal:  Endocrine       Date:  2021-03-08       Impact factor: 3.633

Review 5.  Machado-Joseph disease in a Nigerian family: mutational origin and review of the literature.

Authors:  Shamsideen Abayomi Ogun; Sandra Martins; Philip B Adebayo; Clara O Dawodu; Jorge Sequeiros; Michael F Finkel
Journal:  Eur J Hum Genet       Date:  2014-04-30       Impact factor: 4.246

6.  Genetic testing for clinically suspected spinocerebellar ataxias: report from a tertiary referral centre in India.

Authors:  Sowmya Devatha Venkatesh; Mahesh Kandasamy; Nagaraj S Moily; Radhika Vaidyanathan; Lakshmi Narayanan Kota; Syama Adhikarla; Ravi Yadav; Pramod Kumar Pal; Sanjeev Jain; Meera Purushottam
Journal:  J Genet       Date:  2018-03       Impact factor: 1.166

7.  High frequency of Machado-Joseph disease identified in southeastern Chinese kindreds with spinocerebellar ataxia.

Authors:  Shi-Rui Gan; Sheng-Sheng Shi; Jian-Jun Wu; Ning Wang; Gui-Xian Zhao; Sheng-Tong Weng; Shen-Xing Murong; Chuan-Zhen Lu; Zhi-Ying Wu
Journal:  BMC Med Genet       Date:  2010-03-25       Impact factor: 2.103

Review 8.  Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean.

Authors:  Roberto Rodríguez-Labrada; Ana Carolina Martins; Jonathan J Magaña; Yaimeé Vazquez-Mojena; Jacqueline Medrano-Montero; Juan Fernandez-Ruíz; Bulmaro Cisneros; Helio Teive; Karen N McFarland; Maria Luiza Saraiva-Pereira; César M Cerecedo-Zapata; Christopher M Gomez; Tetsuo Ashizawa; Luis Velázquez-Pérez; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2020-06       Impact factor: 3.847

Review 9.  Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.

Authors:  Kritika Raj; Ravi Shankar Akundi
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

10.  'Costa da Morte' ataxia is spinocerebellar ataxia 36: clinical and genetic characterization.

Authors:  María García-Murias; Beatriz Quintáns; Manuel Arias; Ana I Seixas; Pilar Cacheiro; Rosa Tarrío; Julio Pardo; María J Millán; Susana Arias-Rivas; Patricia Blanco-Arias; Dolores Dapena; Ramón Moreira; Francisco Rodríguez-Trelles; Jorge Sequeiros; Angel Carracedo; Isabel Silveira; María J Sobrido
Journal:  Brain       Date:  2012-04-03       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.